1. Home
  2. ALOT vs CUE Comparison

ALOT vs CUE Comparison

Compare ALOT & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALOT
  • CUE
  • Stock Information
  • Founded
  • ALOT 1969
  • CUE 2014
  • Country
  • ALOT United States
  • CUE United States
  • Employees
  • ALOT N/A
  • CUE N/A
  • Industry
  • ALOT Computer peripheral equipment
  • CUE Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALOT Technology
  • CUE Health Care
  • Exchange
  • ALOT Nasdaq
  • CUE Nasdaq
  • Market Cap
  • ALOT 69.2M
  • CUE 58.9M
  • IPO Year
  • ALOT N/A
  • CUE 2018
  • Fundamental
  • Price
  • ALOT $9.37
  • CUE $0.65
  • Analyst Decision
  • ALOT
  • CUE Strong Buy
  • Analyst Count
  • ALOT 0
  • CUE 3
  • Target Price
  • ALOT N/A
  • CUE $3.00
  • AVG Volume (30 Days)
  • ALOT 14.7K
  • CUE 163.7K
  • Earning Date
  • ALOT 06-05-2025
  • CUE 05-12-2025
  • Dividend Yield
  • ALOT N/A
  • CUE N/A
  • EPS Growth
  • ALOT N/A
  • CUE N/A
  • EPS
  • ALOT N/A
  • CUE N/A
  • Revenue
  • ALOT $151,283,000.00
  • CUE $7,991,000.00
  • Revenue This Year
  • ALOT N/A
  • CUE N/A
  • Revenue Next Year
  • ALOT N/A
  • CUE $25.99
  • P/E Ratio
  • ALOT N/A
  • CUE N/A
  • Revenue Growth
  • ALOT 2.16
  • CUE 13.83
  • 52 Week Low
  • ALOT $7.53
  • CUE $0.45
  • 52 Week High
  • ALOT $18.25
  • CUE $1.99
  • Technical
  • Relative Strength Index (RSI)
  • ALOT 60.25
  • CUE 40.82
  • Support Level
  • ALOT $9.07
  • CUE $0.61
  • Resistance Level
  • ALOT $9.52
  • CUE $0.71
  • Average True Range (ATR)
  • ALOT 0.40
  • CUE 0.06
  • MACD
  • ALOT 0.05
  • CUE -0.00
  • Stochastic Oscillator
  • ALOT 55.32
  • CUE 30.70

About ALOT AstroNova Inc.

AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Share on Social Networks: